UDU-31483-62115
4 vaccinations
6 coded responses
52 check-ins
6 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 566 / MN
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Rash, not including the immediate area around the injection siteAdult check-in
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2020-12-22
-
2020-12-26
Health check-in — day 7, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-31
Survey response — day 14, dose 1MedDRA: Dizziness, Fatigue, Headache — Feeling: Poor · Be unable to workFree text: Headache, dizziness, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to workFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-10
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
-
2021-01-21
Survey response — day 14, dose 2MedDRA: Condition aggravated, Dizziness, Migraine, Vertigo — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Dizziness/vertigo yesterday and this morning. This can be normal with migraine, but it has worsened since vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — day 21, dose 2MedDRA: Dizziness, Migraine, Vertigo — Feeling: Fair · Be unable to workFree text: Dizziness/vertigo with migraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
-
2021-02-11
Survey response — day 35, dose 2MedDRA: Migraine — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Increase in Migraines-number, intensity, and duration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-18
Survey response — day 42, dose 2MedDRA: Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Migraine worseningMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-08
- 2021-07-10
- 2021-07-20
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-05
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-09
- 2021-10-14
- 2021-10-21
- 2021-10-30
- 2021-11-04
- 2021-11-11
- 2021-12-30
- 2022-03-31
- 2022-10-02
-
2022-10-31
Dose 4 — Moderna
-
2022-11-01
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-11-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-11-03
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Muscle or body achesAdult check-in
-
2022-11-04
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-14
- 2022-11-21
- 2022-11-28
- 2022-12-05
- 2022-12-12
- 2023-02-01
- 2023-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-10-31 | Moderna | No |
Call center
5 call center cases
1 unsuccessful · 4 priority 2/3 (triaged and no follow up)
1 wait over 3 months for a first call
Free text
Release 1 — day 14, dose 1
Symptoms: Headache, dizziness, fatigue
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 2 — day 14, dose 2
Symptoms: Dizziness/vertigo yesterday and this morning. This can be normal with migraine, but it has worsened since vaccine.
Release 3 — day 21, dose 2
Symptoms: Dizziness/vertigo with migraine
Release 4 — day 35, dose 2
Symptoms: Increase in Migraines-number, intensity, and duration.
Release 4 — day 42, dose 2
Symptoms: Migraine worsening
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release